Biohacker, entrepreneur and Blueprint creator will appear in person alongside leading scientists, investors and innovators at FLF London 2025.
The Founders Longevity Forum returns to London on 10 June, once again bringing together a curated cohort of longevity investors, biotech entrepreneurs and translational scientists. The forum, co-hosted by Founders Forum Group and Longevity.Technology, will take place at OXO2 – a central, riverside venue – as part of London Tech Week.
The event’s agenda spans diagnostics, preventative therapeutics, age-reversal interventions and the role of AI in population-scale health – but this year’s headline news is that Bryan Johnson will take to the stage in person for a keynote address, Blueprinting the Future: Bryan Johnson on Optimising Life and Defying Death. In what promises to be a provocative session, Johnson will share his bold vision for the future of aging, trace the evolution of his Blueprint protocol, and reflect on the challenges and insights of building in the longevity space. He will also explore how deep self-measurement is shaping new systems for health and performance. The keynote will be followed by a Q&A, offering the audience a rare opportunity to engage directly with one of the most audacious and scrutinised figures in the field.
Johnson, best known as the creator of Blueprint – an intensive self-optimization protocol built around continuous data tracking, dietary precision and clinical-grade interventions – has become one of the most polarising figures in longevity. Once a tech entrepreneur who founded the payments company Braintree – which acquired Venmo in 2012 before being bought by PayPal for $800 million the following year, he has since repositioned himself as a self-experimenting longevity subject, pouring millions into a program designed to reverse biological age across multiple organs and systems.
Described as “the world’s most measured human,” Johnson’s quantified life has made him both a media magnet and a flashpoint for debate about the future of human enhancement; he is also the subject of the recent Netflix documentary Don’t Die: The Man Who Wants to Live Forever, which follows his mission to outpace aging through radical intervention and relentless measurement.
Longevity.Technology: Bryan Johnson’s in-person appearance at Founders Longevity Forum London is more than a headline – it’s a clear signal that Europe’s longevity ecosystem is stepping confidently onto the global stage. For a high-profile US-based figure to commit to a live appearance – rather than dialling in via video – reflects the Forum’s growing influence and the sector’s accelerating momentum. His keynote address offers a rare and timely opportunity to go beyond the polished narratives and media soundbites, exploring the thinking behind Johnson’s audacious Blueprint and his broader philosophical lens on aging, identity and biological optimization.
Johnson’s approach is divisive, but that’s part of his value. He represents a new breed of longevity pioneer – one who brings systems engineering, data obsession and an unapologetically personal stake in the outcome. This convergence of technology, self-experimentation and big-picture vision is pushing the longevity conversation into new territory. His presence at FLF London signals a vital transition: from closed scientific circles to a cross-disciplinary, culturally resonant movement. This isn’t about replacing rigorous science – it’s about expanding the conversation, opening the space to challenge assumptions and creating a stage where biotech, ethics, policy and ambition collide. For the audience, Johnson’s appearance offers something rare in this space: a chance to experience provocation, perspective and possibility – live and unfiltered.
Phil Newman, CEO and Founder of Longevity.Technology, is looking forward to the keynote. “Bryan Johnson is one of the most visible and thought-provoking figures in the longevity space today – and having him join us in person at Founders Longevity Forum London reflects just how quickly this sector is evolving,” he said. “His systems-based, data-driven approach challenges traditional models of aging and healthcare, and we’re looking forward to a candid conversation that gets beneath the surface. This event is about accelerating progress, opening up dialogue and pushing boundaries – and Bryan’s presence will help us do exactly that.”
The 2025 forum will also feature leading voices in epigenetics, consumer-facing diagnostics, longevity clinic models and therapeutic innovation, including Laura Deming, Greg Bailey, Brent Hoberman, Daniel Ives and Bill Kapp, among others. The program aims to offer practical insight into both the science and strategy behind emerging longevity ventures – from translational research to investment readiness, clinical deployment and regulatory navigation.
Attendees will explore how AI and machine learning are being deployed to identify aging biomarkers, personalize interventions and scale access – a theme that sits neatly alongside Johnson’s own emphasis on algorithmic feedback and biological telemetry. His presence brings not just visibility but a broader challenge: to think beyond conventional metrics of success and toward a more holistic, systems-level view of healthspan and self-governance.
As longevity innovation continues to break free from niche corners of academia and biotech, forums like FLF provide an increasingly vital space for ideas to meet investment, for science to inform strategy – and for the field to move forward at pace and with purpose.
